Seagen Canada
Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.
As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology.
We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.
We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.
Biotechnology, Global Pharmaceutical Corporations
- Antibodies
- Antigen
- Immune Therapy
- Oncology
- Therapeutics
Contract Manufacturing, Contract Research & Scientific Services
Member Profile
Biotechnology, Global Pharmaceutical Corporations
Seagen Canada
Bronze Sponsor

- Website www.seagen.com/
- Phone +1 (833) 944 6546
- Email OfficeofSeagenCanada@seagen.com
- Address
2000 Argentia Road Plaza 3, Suite 400
Mississauga, Ontario
L5N 1V9 - Leadership Contact
Collette Williams, Senior Manager, Value & Access